BOCIC(SH:601696) Xin Lang Cai Jing·2025-11-07 06:25Core Viewpoint - Zai Jian Pharmaceutical has experienced a significant decline in stock price, dropping 5.06% on November 7, with a total market value of 24.954 billion yuan and a cumulative drop of 6.33% over three consecutive days [1][2] Company Overview - Zai Jian Pharmaceutical, established on March 18, 2009, is located in Kunshan, Jiangsu Province, and was listed on January 23, 2020. The company focuses on the research, production, and sales of chemical and biological new drugs [1] - The main revenue composition of the company is 99.97% from pharmaceuticals, 0.02% from pharmaceutical intermediates and raw materials, and 0.00% from asset leasing [1] Fund Holdings - A fund under Bank of China Securities holds Zai Jian Pharmaceutical as its third-largest position, with a reduction of 4,000 shares in the third quarter, now holding 128,000 shares, which constitutes 9.08% of the fund's net value [2] - The fund, Zhongyin Securities Health Industry Mixed Fund (002938), has a total scale of 159 million yuan and has experienced a year-to-date return of 38.52%, ranking 2089 out of 8148 in its category [2] - The fund manager, Li Mingwei, has been in position for 2 years and 260 days, with the best and worst fund returns during his tenure being -6.79% [2]